Title : AXL as a modulator of sunitinib response in glioblastoma cell lines.

Pub. Date : 2015 Mar 1

PMID : 25637219






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 We recently identified the RTK AXL as a putative target for the pan-RTK inhibitors cediranib and sunitinib, which are under clinical trials for glioblastoma patients. Sunitinib ret proto-oncogene Homo sapiens
2 We recently identified the RTK AXL as a putative target for the pan-RTK inhibitors cediranib and sunitinib, which are under clinical trials for glioblastoma patients. Sunitinib ret proto-oncogene Homo sapiens